Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Change in Inventory (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Change in Inventory for 6 consecutive years, with $1.6 million as the latest value for Q4 2021.

  • Quarterly Change in Inventory rose 134.0% to $1.6 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $694958.0 through Dec 2021, up 45.95% year-over-year, with the annual reading at -$235731.0 for FY2024, 302.88% down from the prior year.
  • Change in Inventory for Q4 2021 was $1.6 million at ENDRA Life Sciences, up from -$174952.0 in the prior quarter.
  • The five-year high for Change in Inventory was $1.6 million in Q4 2021, with the low at -$872159.0 in Q2 2021.
  • Average Change in Inventory over 5 years is $76600.6, with a median of $25363.5 recorded in 2018.
  • The sharpest move saw Change in Inventory surged 41022.73% in 2018, then plummeted 4812400.0% in 2020.
  • Over 5 years, Change in Inventory stood at $60000.0 in 2017, then fell by 0.93% to $59444.0 in 2018, then plummeted by 124.21% to -$14389.0 in 2019, then soared by 4867.14% to $685944.0 in 2020, then soared by 134.0% to $1.6 million in 2021.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $1.6 million, -$174952.0, and -$872159.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.